Biolife Solutions M&A Deal with Repligen Corporation
BioLife Solutions completed its merger with Repligen Corporation, becoming a wholly owned subsidiary of Repligen. BioLife stockholders received 0.1442 shares of Repligen common stock and $11.25 in cash for each share of BioLife common stock held. As a result of the completion, BioLife's common stock will be delisted from the Nasdaq Stock Market.
Paramount Skydance M&A Deal with Warner Bros. Discovery, Inc.
Paramount Skydance Corp (now Skydance Corporation) completed its acquisition of Warner Bros. Discovery, Inc., creating a combined global entertainment leader. In connection with the closing, the company issued $41.4 billion in senior secured notes and transferred its stock listing to the NYSE under the ticker 'SKYD'.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. has filed a Notice of Variation to its existing tender offer to acquire all outstanding shares of Aurora Cannabis Inc. The amended offer increases the consideration to US$1.00 in cash plus 0.4013 Curaleaf subordinate voting shares per Aurora share and extends the expiry date to December 4, 2026.
Auddia Inc. cancelled its special stockholder meeting intended to vote on its proposed merger with Thramann Holdings because it failed to secure approval from a majority of outstanding shares, despite 89% of cast votes being in favor. The company plans to establish a new record date and reschedule the meeting to allow shareholders to evaluate recent strategic momentum regarding LT350's AI infrastructure platform. The merger, originally announced in February 2026, would form a new AI-native operating company called McCarthy Finney.
Option Care Health Signs $5.8B M&A Deal with Investor Group
Option Care Health has entered into a definitive agreement to be acquired by an investor group led by Clayton, Dubilier & Rice (CD&R) and McKesson Corporation for $32.05 per share in cash. The transaction reflects a total enterprise value of approximately $5.8 billion and will result in Option Care Health becoming a privately held company with CD&R as the majority owner.
Mckesson Signs $5.8B M&A Deal with Option Care Health, Inc.
McKesson Corporation and Clayton, Dubilier & Rice (CD&R) have entered into a definitive agreement to acquire Option Care Health for $32.05 per share, representing a total enterprise value of approximately $5.8 billion. Upon closing, CD&R will hold a majority stake while McKesson will hold a minority interest in the home and alternate site infusion services provider. The deal aligns with McKesson's strategy to expand access to innovative therapies in lower-cost community and home settings.
Indivior Pharmaceuticals M&A Deal with Supernus Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc. provided a status update on its pending merger with Supernus Pharmaceuticals, Inc., specifically addressing supplemental disclosures to the joint proxy statement/prospectus. The update follows demand letters and complaints from Supernus stockholders alleging disclosure deficiencies, which the company believes are meritless but is addressing to avoid litigation risk. The special meetings for stockholders of both companies to vote on the merger are scheduled for October 15, 2026.
Novagold Resources M&A Deal with Paulson Advisers LLC
NOVAGOLD has filed and commenced mailing proxy materials for a special meeting on November 3, 2026, to approve the acquisition of the remaining 40% interest in Donlin Gold LLC from Paulson Advisers LLC. The all-share transaction will increase NOVAGOLD's ownership of the Donlin Gold project in Alaska from 60% to 100% and involve a re-domestication to Delaware.
Fathom Holdings M&A Deal with Neighborhood Intelligence, Inc.
Fathom Holdings and Neighborhood Intelligence (formerly Bed Bath & Beyond) have mutually agreed to terminate their previously announced merger agreement, citing that current market valuations do not reflect the fair value of either company. No termination fees will be owed by either party, and the companies intend to explore future strategic collaborations such as data sharing. Additionally, Fathom extended the maturity date of its senior secured convertible promissory notes to November 1, 2026, and lowered the conversion price to $0.65 per share.
Non Invasive Monitoring Systems Signs $125M M&A Deal with Gravitics, Inc.
Non-Invasive Monitoring Systems entered into a third amendment to its merger agreement with Gravitics, Inc., extending the closing deadline to October 30, 2026. The amendment significantly increases the target size of the associated underwritten public offering from $40 million to $125 million and modifies debt repayment terms for company affiliates. Additionally, the company extended the maturity of an $809,705 convertible note to align with the new merger timeline.
Evernorth Holdings M&A Deal with Armada Acquisition Corp. II
Evernorth Holdings Inc. provided a status update on its pending business combination with Armada Acquisition Corp. II regarding an amendment to Armada II's existing warrant agreement. The amendment aligns the warrant exercise period with the terms originally disclosed in the IPO prospectus, making them exercisable 12 months after the IPO or upon the closing of the merger. The transaction will result in Evernorth becoming a publicly traded digital asset treasury focused on XRP exposure.
Novagold Resources M&A Deal with Paulson Advisers LLC
NOVAGOLD Resources Inc. provided a status update on its previously announced merger and reorganization into a new Delaware corporation, New NovaGold. Under the definitive agreements, New NovaGold will acquire all outstanding shares of the company and the 40% interest in the Donlin Gold project currently held by Paulson Advisers LLC, resulting in New NovaGold owning 100% of the project. The transaction remains subject to shareholder, court, and regulatory approvals.
American Resources Signs $40M M&A Deal with Wyoming County Coal LLC
American Resources Corporation acquired real property, structures, and equipment in Wyoming County, West Virginia, from Wyoming County Coal LLC for $40 million. The consideration was paid through the settlement of pending litigation in the U.S. District Court for the Southern District of Indiana. The company intends to utilize the assets, including mineral rights in legacy refuse piles, as part of its critical-mineral feedstock and resource strategy.
Chiron Real Estate Signs $173M M&A Deal with Silverstone Senior Living
Chiron Real Estate Inc. completed the acquisition of The Pinnacle North Bethesda, a senior housing community in Maryland, for $173.2 million. The transaction was funded through cash on hand and $171 million in additional debt incurred under the company's existing credit facility. Greystone Communities has been appointed as the third-party operator to manage the property's day-to-day operations.
Champion Homes M&A Deal with Timberline Homes, Inc.
Champion Homes, Inc. has entered into a definitive agreement to acquire the assets of Timberline Homes, Inc., which includes nine retail locations across Alabama, Mississippi, and Florida. The acquisition is intended to expand Champion's retail footprint in the Southeastern U.S. and accelerate its direct-to-consumer strategy. The transaction is expected to close in the fourth quarter of Champion's fiscal year 2027.
Peoples Bancorp M&A Deal with Capital Bancorp, Inc.
Peoples Bancorp Inc. (PEBO) has entered into a definitive agreement to acquire Rockville, Maryland-based Capital Bancorp, Inc. Management described the transaction as a transformational combination that adds scale and a differentiated set of businesses to the Peoples franchise.
Construction Partners M&A Deal with J.H. Strain & Sons, Inc.
Construction Partners, Inc. (CPI) has completed the acquisition of the asphalt manufacturing and construction assets of J.H. Strain & Sons, Inc., based in Tye, Texas. The deal adds two hot-mix asphalt plants and over 125 employees to CPI's Texas platform, Lone Star Paving, expanding its presence in the Abilene and West Texas markets.
Counterparty
J.H. Strain & Sons, Inc.
“The addition of J.H. Strain’s two hot-mix asphalt plants, fleet and experienced workforce provides Lone Star with a strong local presence from which to serve public and private infrastructure customers throughout the greater Abilene area and West Texas.”
Fred J. (Jule) Smith, III, the Company’s President and Chief Executive Officer
iRhythm Holdings Signs $238M M&A Deal with Vital Connect, Inc.
iRhythm Holdings completed its acquisition of Vital Connect, Inc. for $237.5 million in cash. The deal expands iRhythm's cardiac monitoring portfolio into mobile cardiac telemetry (MCT) and multi-vitals monitoring across ambulatory, inpatient, and hospital-to-home care settings.
Qorvo, Inc. completed its previously announced merger with Skyworks Solutions, Inc., becoming a wholly owned subsidiary of Skyworks. Under the terms of the agreement, Qorvo stockholders received 0.960 shares of Skyworks common stock for each share of Qorvo common stock held. In connection with the closing, Qorvo terminated its existing credit agreement with Bank of America.
Skyworks Solutions completed its acquisition of Qorvo, Inc. in a cash-and-stock merger where Qorvo stockholders received $32.50 in cash and 0.960 shares of Skyworks common stock per share. The combined company expects to realize over $500 million in annual cost synergies and will continue to trade under the ticker SWKS.
Axe Compute Signs $131M M&A Deal with Duos Technologies Group, Inc.
Axe Compute acquired 100% of a special purpose vehicle from Duos Technologies Group that owns an AI cluster in Georgia consisting of 2,304 NVIDIA B300 GPUs. The transaction involved retiring $87.8 million in debt and a $42.9 million deferred purchase price, while simultaneously extending the cluster's customer agreement to a five-year term expected to generate $364.6 million in revenue.
Value
$131M
Counterparty
Duos Technologies Group, Inc.
Term
5 years
“In another validation of our partnership with Duos, we are taking this step so we can both focus on what we do best. Duos is a world class data center builder and we are fortunate to call them a partner. Our customer is committed for five years, our power and facility costs are covered for five years, and we own our GPUs. That alignment is expected to significantly expand the margin profile and return on this existing cluster.”
Christopher Miglino, Chief Executive Officer of Axe Compute
“This is the right move for both companies, and our relationship with Axe Compute has never been stronger. It streamlines the Georgia structure so Axe Compute can focus on what it does exceptionally well, delivering AI clusters to its customers. Duos stays focused on what we do best, providing the power and infrastructure behind them, now under a five-year partnership.”
Doug Recker, Chief Executive Officer of Duos Technologies Group
SIM Acquisition Corp. I M&A Deal with American Industrial Technologies, Inc.
SIM Acquisition Corp. I entered into a binding Letter of Intent to acquire 100% of American Industrial Technologies, Inc. (AIT) in a business combination. Upon closing, SIM will issue approximately 50,000,000 shares to AIT equity holders, and AIT's CEO John Chiorando will become the CEO and Chairman of the combined company. The agreement includes a $5 million termination fee payable to SIM under certain conditions if the deal fails to proceed.
C. H. Robinson Worldwide Signs $5.8B M&A Deal with RXO, Inc.
C.H. Robinson Worldwide, Inc. has entered into a definitive agreement to acquire RXO, Inc. in a stock-and-cash transaction with an implied value of $5.8 billion. The deal combines two major North American third-party logistics providers and is expected to generate $300 million in annual cost synergies within two years of closing. The transaction is expected to close in the first half of 2027, creating a combined company with an enterprise value of over $25 billion.
Value
$5.8B
Counterparty
RXO, Inc.
Earnings call
Oct 2, 2026, 8:00 AM ET
“This transaction is a natural next step in our transformation, allowing us to create a more scaled, resilient North American third-party logistics provider positioned to offer exceptional customer service and redefine the future of our industry.”
Dave Bozeman, C.H. Robinson President and Chief Executive Officer
“Joining C.H. Robinson represents an exciting next chapter for our company, our employees and our customers. We have built a strong business by staying relentlessly focused on our customers, operating with agility and delivering solutions that help them navigate an increasingly complex supply chain.”
Drew Wilkerson, RXO Chairman and Chief Executive Officer
RXO Signs $5.8B M&A Deal with C.H. Robinson Worldwide, Inc.
RXO, Inc. has entered into a definitive agreement to be acquired by C.H. Robinson in a stock-and-cash transaction with an implied value of $5.8 billion. RXO stockholders can elect to receive $30.25 in cash, 0.1992 shares of C.H. Robinson stock, or a standard combination of both per share. The deal is expected to close in the first half of 2027 and create a combined logistics company with an enterprise value exceeding $25 billion.
Benitec Biopharma M&A Deal with U.S. Food and Drug Administration
Benitec Biopharma provided a status and timeline update for its BB-301 program following a Type C meeting with the FDA. The company remains on track to initiate a pivotal study in mid-2027, with the final study design expected to be confirmed in Q1 2027 after the FDA reviews additional natural history data.
Distribution Solutions Group Signs $700M M&A Deal with LKCM Headwater Investments, LLC
Distribution Solutions Group (DSG) announced a $700 million senior notes offering to fund its previously announced merger with affiliates of LKCM Headwater Investments. Under the deal, LKCM Headwater will acquire all outstanding shares of DSG it does not already own for $35.00 per share in cash, taking the company private.
Matador Resources Signs $1.27B M&A Deal with Paloma Permian, LLC
Matador Resources Company completed its acquisition of Paloma Permian, LLC for a cash purchase price of $1.275 billion. The deal adds approximately 16,500 net acres and over 156 net drilling locations in the Delaware Basin (Eddy and Lea Counties, New Mexico). Matador paid an as-adjusted closing price of $1.255 billion and expects to integrate the assets into its existing upstream and midstream operations.
Harrow, Inc. completed the acquisition of the dry eye disease treatment TYRVAYA from Viatris for $30 million in cash at closing. The deal includes worldwide rights except for Japan, where Viatris will pay Harrow royalties on future sales. Harrow may also pay up to $70 million in contingent milestone payments based on net sales thresholds through 2029.
PTC Signs $22.6B M&A Deal with Schneider Electric SE
PTC Inc. has entered into a definitive agreement to be acquired by Schneider Electric SE for $205 per share in an all-cash transaction. The deal values PTC's equity at approximately $22.6 billion and will result in PTC becoming a wholly owned subsidiary of Schneider Electric, creating a scaled industrial software and AI franchise.
Value
$22.6B
Counterparty
Schneider Electric SE
Earnings call
Oct 5, 2026, 9:00 AM ET
“The acquisition of PTC represents an important step forward in our ambition to lead the new era of Energy and Industrial Intelligence. Together, we are creating the industry’s most complete Software & AI powerhouse and highest-quality portfolio bridging the physical and digital worlds.”
Olivier Blum, Chief Executive Officer of Schneider Electric
“Joining Schneider Electric is an incredible opportunity to elevate the scope and impact of what we deliver for our customers globally. We gain substantial scale and resources to accelerate innovation, advance our Intelligent Product Lifecycle vision, and expand our business into more geographies and end markets to serve more customers.”
Processa Pharmaceuticals M&A Deal with Vidya Therapeutics, Inc.
Processa Pharmaceuticals filed an amendment to its 8-K to provide audited financial statements and pro forma information following its acquisition of Vidya Therapeutics. The deal adds VT7208, a CNS-penetrant BTK inhibitor, to Processa's pipeline for the treatment of autoimmune conditions like multiple sclerosis and food allergies.